Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience
- 1 March 2006
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (2) , 866-874
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Secondary chemotherapy for high-risk gestational trophoblastic neoplasiaGynecologic Oncology, 2005
- The use of taxanes in choriocarcinoma; a case report and review of the literatureGynecologic Oncology, 2004
- Successful treatment of mother and baby with metastatic choriocarcinomaInternational Journal of Gynecological Cancer, 2002
- FIGO staging for gestational trophoblastic neoplasia 2000International Journal of Gynecology & Obstetrics, 2002
- Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer SocietyInternational Journal of Gynecological Cancer, 2000
- The Management of Gestational Trophoblastic Tumors with Etoposide, Methotrexate, and Actinomycin DGynecologic Oncology, 1997
- Remission of refractory gestational trophoblastic disease with high-dose paclitaxelAnti-Cancer Drugs, 1996
- Treatment of Resistant Gestational Choriocarcinoma with Taxol: A Report of Two CasesGynecologic Oncology, 1996
- Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989BJOG: An International Journal of Obstetrics & Gynaecology, 1991
- Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)BJOG: An International Journal of Obstetrics & Gynaecology, 1986